Skip to main content
ENVB logo

Enveric Biosciences, Inc.

ENVBNASDAQHealthcareBiotechnology

$1.38Today:- (-)1Y −84.74%

As of Oct 16, 2026 close

Market cap
$5.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.17$13.25
Volume (live)
-
Avg. volume (3M)
69.97K

Enveric Biosciences (ENVB) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Enveric Biosciences used $8.14M of cash in operating activities. Free cash flow was −$8.14M.

Enveric Biosciences Cash Flow Statement Analysis

Values in trillions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Enveric Biosciences, Inc. (ENVB) - Annual data in trillions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income0.000.000.000.000.000.000.000.000.000.000.00
Depreciation & Amortization0.000.000.000.000.000.000.000.000.000.000.00
Deferred Income Tax0.000.000.000.000.000.000.00-0.000.000.00
Stock Based Compensation0.000.000.000.000.000.000.000.000.000.000.00
Change in Working Capital0.000.000.000.000.000.000.000.000.000.000.00
Change in Accounts Receivable0.000.000.000.000.00-0.00-0.000.000.00
Change in Accounts Payable0.000.000.000.000.000.000.000.000.000.000.00
Change in Other Working Capital0.000.000.000.000.000.000.000.000.000.000.00
Other Operating Activities0.000.000.000.000.000.000.000.000.000.000.00
Net Cash from Operating Activities0.000.000.000.000.000.000.000.000.000.000.00
Investing Activities
Capital Expenditures0.000.000.000.000.000.000.00-0.000.000.00
Acquisitions0.000.000.000.000.000.000.00-0.000.000.00
Sales/Maturities of Investments0.000.000.000.000.000.000.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.00-0.000.000.00
Net Cash from Investing Activities0.000.000.000.000.000.000.000.000.000.000.00
Financing Activities
Debt Repayment0.000.000.000.000.00-0.000.000.000.000.00
Common Stock Issued0.000.000.000.000.000.000.000.000.000.000.00
Common Stock Repurchased0.000.000.000.000.00-0.00-0.000.000.00
Dividends Paid0.000.000.000.000.00-0.00-0.00-2.090.00
Other Financing Activities0.000.000.000.000.00-0.00-0.000.000.00
Net Cash from Financing Activities0.000.000.000.000.000.000.000.000.000.000.00
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.00-0.000.000.00
Net Change in Cash0.000.000.000.000.000.000.000.000.000.000.00
Cash at Beginning of Period0.000.000.000.000.000.000.00-0.000.000.00
Cash at End of Period0.000.000.000.000.000.000.00-0.000.000.00
Free Cash Flow0.000.000.000.000.000.000.000.000.000.000.00
Supplemental Disclosures
Interest Paid---0.00-0.00-----
Income Taxes Paid-0.000.00--------

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Enveric Biosciences Cash Flow

What is Enveric Biosciences's free cash flow?

Enveric Biosciences had negative free cash flow of $8.14M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Enveric Biosciences pay dividends or buy back shares?

Enveric Biosciences's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition